Treatment-refractory ulcerative colitis responsive to indigo naturalis
Background Indigo naturalis (IN) is an herbal medicine that has been used for ulcerative colitis with an unclear mechanism of action. Indigo and indirubin, its main constituents, are ligands of the aryl hydrocarbon receptor (AhR). We assessed the safety, efficacy, and colon AhR activity of IN given...
Saved in:
| Main Authors: | Berkeley Limketkai, Julie P Saiki, Johan OL Andreasson, Kevin V Grimes, Lyn R Frumkin, Elvi Sanjines, Matthew G Davidson, KT Park |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-10-01
|
| Series: | BMJ Open Gastroenterology |
| Online Access: | https://bmjopengastro.bmj.com/content/8/1/e000813.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Indigo naturalis as a potential drug in the treatment of ulcerative colitis: a comprehensive review of current evidence
by: Yu Hu, et al.
Published: (2024-12-01) -
Evaluation of Indigo Naturalis Prepared Using a Novel Method: Therapeutic Effects on Experimental Ulcerative Colitis in Mice
by: Xianxiang Xu, et al.
Published: (2025-05-01) -
Clinical, pharmacology and in vivo studies of QingDai (indigo naturalis) promotes mucosal healing and symptom improvement in ulcerative colitis by regulating the AHR-Th17/Treg pathway
by: Sizhen Gu, et al.
Published: (2024-11-01) -
Indigo naturalis for inflammatory bowel disease: evidence from animal studies and molecular mechanisms
by: Jie Hu, et al.
Published: (2025-07-01) -
Uncommon Presentation of Autoimmune Pancreatitis With Refractory Ulcerative Colitis
by: Morgan Starkey, et al.
Published: (2022-06-01)